A FAPI-based small-molecule drug conjugate alleviates rheumatoid arthritis by targeting pathogenic FAPα-expressing fibroblasts
Acta Pharmacol Sin. 2026 Jan 1. doi: 10.1038/s41401-025-01680-x. Online ahead of print. ABSTRACT The management of rheumatoid arthritis (RA) has […]
